Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
A blood pressure medication produced by generics giant Sun Pharmaceuticals is being recalled.
Sun Pharma is voluntarily recalling diltiazem hydrochloride in a 360 mg dosage form across the US, according to an enforcement report from the FDA. The drug is used to treat high blood pressure and angina.
The FDA’s report said the recall stems from a “failed impurity specification” during testing as well as another failed test at an FDA laboratory. The report said that the recalled product was produced by Sun Pharma’s facility in Halol, India, a city in the nation’s southwest state of Gujarat. The recall itself was issued on Jan. 13 of this year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
